Abstract
A vast majority of the human genome encodes long non-coding RNAs (lncRNAs) as compared to protein-coding genes (PCGs). But most efforts to determine biomarkers of anticancer drug response have focused entirely on PCGs. Comprehensive investigation of lncRNAs and drug response demonstrates that lncRNAs are indeed crucial biomarkers of drug response.
| Original language | English (US) |
|---|---|
| Article number | 1684130 |
| Journal | Molecular and Cellular Oncology |
| Volume | 7 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2 2020 |
Bibliographical note
Publisher Copyright:© 2019, © 2019 Taylor & Francis Group, LLC.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Long non-coding RNA
- drug response prediction
- pharmacogenomics
Fingerprint
Dive into the research topics of 'Emerging role of long non-coding RNAs in cancer precision medicine'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS